Product Information
FENOFIBRATE 145 MG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1198 per EA under NDC 68180038902. Its NADAC has been published 286 times since Jan 6, 2021.
The High Outlier badge above means this manufacturer's average price in the Fenofibrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
145 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180038902
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA090856On Market Since
8/1/2020
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 145 MG TABLET has been published 286 times since Jan 6, 2021, and over the history we have for it it has declined 39.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1198 per EA |
|---|---|
| All-time high | $0.2627 (Mar 10, 2021) |
| All-time low | $0.1088 (Nov 20, 2024) |
| 52-week high | $0.1348 |
| 52-week low | $0.1130 |
| Median price | $0.1471 |
| Average price | $0.1528 |
| Largest weekly change | +25.3% (Jan 20, 2021) |
| Weeks tracked | 286 |
| Tracking since | Jan 6, 2021 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 145 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 145 MG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1198 per EA (NDC 68180038902), effective Jun 24, 2026.
How has the price of FENOFIBRATE 145 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 145 MG TABLET has declined 39.8%. It has been tracked across 286 weekly CMS publications since Jan 6, 2021.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 145 MG TABLET?
Since Jan 6, 2021, the NADAC for FENOFIBRATE 145 MG TABLET has ranged from a low of $0.1088 (Nov 20, 2024) to a high of $0.2627 (Mar 10, 2021), with a median of $0.1471 per EA.
Are there cheaper alternatives to FENOFIBRATE 145 MG TABLET?
7 NADAC-published products share the same active ingredient, strength, and dosage form as FENOFIBRATE 145 MG TABLET, but none are currently priced below it.
Who manufactures FENOFIBRATE 145 MG TABLET?
FENOFIBRATE 145 MG TABLET (NDC 68180038902) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification